MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.
Abstract
In microorganisms, evolutionarily conserved mechanisms facilitate adaptation to harsh conditions through stress-induced mutagenesis (SIM). Analogous processes may underpin progression and therapeutic failure in human cancer. We describe SIM in multiple in vitro and in vivo models of human cancers under nongenotoxic drug selection, paradoxically enhancing adaptation at a competing intrinsic fitness cost. A genome-wide approach identified the mechanistic target of rapamycin (MTOR) as a stress-sensing rheostat mediating SIM across multiple cancer types and conditions. These observations are consistent with a two-phase model for drug resistance, in which an initially rapid expansion of genetic diversity is counterbalanced by an intrinsic fitness penalty, subsequently normalizing to complete adaptation under the new conditions. This model suggests synthetic lethal strategies to minimize resistance to anticancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mTOR is frequently activated in cancer, stimulates cell growth, facilitates adaptive evolution, and contributes to tumor metabolic reprogramming by rewiring glucose, amino acid, nucleotide, fatty acid, and lipid metabolism.224,225”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [225]
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
HISAT: a fast spliced aligner with low memory requirements
Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
GENCODE: The reference human genome annotation for The ENCODE Project
Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., Kokocinski, F., Aken, B. L., Barrell, D., Zadissa, A., Searle, S., et al. (2012) · Genome Research · doi:10.1101/gr.135350.111 · Cited by 4,585
Research works printed but not linked: 1
- 10.1038/nm.3841 · DOI · Paper page
Cited by
Non-genetic mechanisms of therapeutic resistance in cancer
Marine, J.-C., Dawson, S.-J., & Dawson, M. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00302-4 · Cited by 635
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
Russo, M., Chen, M., Mariella, E., Peng, H., Rehman, S. K., Sancho, E., Sogari, A., Toh, T. S., Balaban, N. Q., Batlle, E., et al. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00737-z · Cited by 210
“This in turn leads to increased genomic instability and a temporary increase of the mutation rate in DTPs, thus momentarily increasing the likelihood of resistance mechanisms being acquired 10,17,188 (Fig.”
InfluentialHe, J., Qiu, Z., Fan, J., Xie, X., Sheng, Q., & Sui, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01891-4 · Cited by 160
“47,48 Furthermore, multiple studies 13,49 – 51 have con fi rmed the generation of the DTP cells under drug induction, with numerous factors inducing cancer cells to transition into the DTP cells, making them a recognized potential source of drug resistance.”
BackgroundGerosa, L., Chidley, C., Fröhlich, F., Sanchez, G., Lim, S. K., Muhlich, J., Chen, J.-Y., Vallabhaneni, S., Baker, G. J., Schapiro, D., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.10.002 · Cited by 110
“Emerging evidence suggests that rapid adaptation to targeted drugs by non-genetic mechanisms promotes sustained survival of persister cells, contributes to residual disease, and facilitates emergence of resistance mutations responsible for disease recurrence in patients (Pazarentzos and Bivona, 2015; Russo et al., 201…”
Background
Metadata
- Authors
- Cipponi, A., Goode, D. L., Bedo, J., McCabe, M. J., Pajic, M., Croucher, D. R., Rajal, A. G., Junankar, S. R., Saunders, D. N., Lobachevsky, P., Papenfuss, A. T., Nessem, D., Nobis, M., Warren, S. C., Timpson, P., Cowley, M., Vargas, A. C., Qiu, M. R., Generali, D. G., Keerthikumar, S., Nguyen, U., Corcoran, N. M., Long, G. V., Blay, J.-Y., & Thomas, D. M.
- Affiliations
- Garvan Institute of Medical Research (AU)
- The University of Melbourne (AU)
- Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
- The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
- UNSW Sydney (AU)
- Peter MacCallum Cancer Centre (AU)
- Douglass Hanly Moir Pathology (AU)
- University of Trieste (IT)
- The Royal Melbourne Hospital (AU)
- The University of Sydney (AU)
- Centre Léon Bérard (FR)
- Corresponding author
- Cipponi, Arcadi
- Thomas, David M.
- ORCID
- Cipponi, Arcadi
- Goode, David L.
- Bedo, Justin
- McCabe, Mark J.
- Pajic, Marina
- Croucher, David R.
- Rajal, Alvaro Gonzalez
- Junankar, Simon R.
- Saunders, Darren N.
- Lobachevsky, Pavel
- Papenfuss, Anthony T.
- Nessem, Danielle
- Nobis, Max
- Warren, Sean C.
- Timpson, Paul
- Cowley, Mark
- Vargas, Ana C.
- Qiu, Min R.
- Generali, Daniele G.
- Keerthikumar, Shivakumar
- Nguyen, Uyen
- Corcoran, Niall M.
- Long, Georgina V.
- Blay, Jean-Yves
- Thomas, David M.
- Venue
- Science
- Published
- 2020-06-05
- Volume
- 368
- Issue
- 6495
- Pages
- 1127-1131
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3033942938
- Cited by
- 103
- References
- 74
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 15 · 2023: 22 · 2022: 16 · 2021: 23 · 2020: 8
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
- Funders
- Cancer Australia (1143699)
- Australian national health and medical research council (APP1088353, APP1162860)
- Girgenshon Foundation
- MEDnoTE Spin-Off University of Trieste (N/A)
- Australian national health and medical resesrach council (APP1162556)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- stress-induced mutagenesis, mTOR signaling, drug resistance, synthetic lethality, genome-wide screen, tumor evolution
- MeSH terms
- Adaptation, Physiological, Antineoplastic Agents, DNA Repair, Humans, Neoplasms, Selection, Genetic, Signal Transduction, Mutagenesis, Drug Resistance, Neoplasm, Cell Line, Tumor, Genome-Wide Association Study, Genetic Fitness, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer. https://app.cochat.ai/papers/10.1126/science.aau8768
- The paper
- Cipponi, A., Goode, D. L., Bedo, J., McCabe, M. J., Pajic, M., Croucher, D. R., Rajal, A. G., Junankar, S. R., Saunders, D. N., Lobachevsky, P., Papenfuss, A. T., Nessem, D., Nobis, M., Warren, S. C., Timpson, P., Cowley, M., Vargas, A. C., Qiu, M. R., Generali, D. G., . . . Thomas, D. M. (2020). MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer. Science. https://doi.org/10.1126/science.aau8768
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.